C4 Therapeutics Taps NIBR’s Crystal for Chief Medical Officer Post

Xconomy Boston — 

Adam Crystal has been appointed chief medical officer of C4 Therapeutics. Crystal comes to the Watertown, MA-based biotech from the Novartis Institutes for BioMedical Research (NIBR), where he led several oncology programs. Before working at NIBR, Crystal was a medical oncologist at Massachusetts General Hospital. C4 is developing drugs that treat disease through protein degradation, a cellular process for disposing of faulty or damaged proteins.